LCZ696 (Valsarta + sacubitril) | C48H57N6Na3O9 | CID 24755604 - PubChem
Sacubitril – Wikipedia
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Is Entresto good for the brain? - Abstract - Europe PMC
Olmesartan | C24H26N6O3 | CID 158781 - PubChem
File:Valsartan.svg - Wikipedia
PharmaWiki - Sacubitril
Frontiers | Neprilysin Inhibitors and Bradykinin
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
VALSARTAN
CardsJC: EMPEROR-Preserved Trial - Cardionerds Twitter Journal Club
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Entresto | C96H120N12Na6O21 | CID 71449007 - PubChem
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
Sacubitril | New Drug Approvals
Sacubitril/Valsartan (LCZ696) | ARN Inhibitor | MedChemExpress
LCZ696 (Valsarta + sacubitril) | C48H57N6Na3O9 | CID 24755604 - PubChem
Sacubitril | New Drug Approvals
